findmyKOL
Clinical trialNCT05303467RecruitingPhase 1Interventional

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

SponsorBoston Scientific CorporationEnrollment36Glioblastoma MultiformeRecurrent Glioblastoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama Birmingham

    Birmingham, Alabama, United States

    Withdrawn
  • University of California San Diego

    San Diego, California, United States

    Zachary Berman, MD
    Not, yet, recruiting
  • University of California San Francisco

    San Francisco, California, United States

    Nicholas Butowski, MD
    Recruiting
  • Mayo Jacksonville

    Jacksonville, Florida, United States

    Alfredo Quinones-Hinojosa, MD
    Recruiting
  • Northwestern Univerity

    Chicago, Illinois, United States

    Samdeep Mouli, MD
    Recruiting
  • Johns Hopkins Interventional Radiology Center

    Baltimore, Maryland, United States

    Withdrawn
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Arindam Chatterjee, M.D.
    Recruiting
  • Lenox Hill Hospital

    New York, New York, United States

    John Boockvar, MD
    Recruiting
  • Md Anderson Cancer Center

    Houston, Texas, United States

    Stephen Chen, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jul 2022
Primary completion
31 Oct 2026
Completion
30 Apr 2027
Last update posted
23 Jun 2026
Registered enrollment
36
Registry id
NCT05303467
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.